Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51

United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026

Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

Insider

Date

Role

Action

Price

Amount

Olivier Loeillot

4 Sep 2026

Chief Executive Officer

Sold on a plan

3,035

$165.90

$503.51K

Jason K Garland

16 Jul 2026

CFO

Sold on a plan

530

$150.00

$79.50K

Jason K Garland

25 Jun 2026

CFO

Sold on a plan

733

$145.00

$106.29K

Olivier Loeillot

21 Apr 2026

Chief Executive Officer

Sold on a plan

3,832

$140.00

$536.48K

Olivier Loeillot

25 Nov 2025

Chief Executive Officer

Sold on a plan

7,041

$170.00

$1.20M

Show all 27 transactions →

What was left out

Form 4 filings counted 42

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 18

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 145,954

History held since 6 Dec 2006